https://techtimesnewyork.com/article/906757110-foldin-opens-public-beta-a-real-life-social-network-designed-around-the-courage-to-show-up Tech Times of New York en PressRelease 2026-04-19T16:19:49+00:00 Foldin Opens Public Beta: A Real-Life Social Network Designed Around the Courage to Show Up https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24835797-foldin-cover-1200x628.png https://techtimesnewyork.com/article/906845683-ascentage-pharma-to-present-four-promising-preclinical-studies-demonstrating-the-potential-of-combination-therapies-at-american-association-for-cancer Tech Times of New York en PressRelease 2026-04-20T00:00:00+00:00 Ascentage Pharma to Present Four Promising Preclinical Studies Demonstrating the Potential of Combination Therapies at American Association for Cancer Research (AACR) 2026 Annual Meeting https://ml.globenewswire.com/media/b9623a51-a13b-4b80-8152-61d5014f4a0a/small/2025-11-12-ascentage-600x600-png.png https://techtimesnewyork.com/article/906845652-sutro-biopharma-presents-promising-preclinical-data-across-its-pipeline-of-next-generation-single-and-dual-payload-adc-programs-at-aacr-2026 Tech Times of New York en PressRelease 2026-04-19T23:45:00+00:00 Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026 https://ml.globenewswire.com/media/b29d64ff-a5d8-41ff-9d46-e0e332cc7f28/small/image001-png.png https://techtimesnewyork.com/article/906841121-monopar-presents-phase-3-data-showing-greater-neurologic-benefit-with-alxn1840-vs-soc-in-wilson-disease-patients-with-neurologic-symptoms-at-aan-2026 Tech Times of New York en PressRelease 2026-04-19T23:00:00+00:00 Monopar Presents Phase 3 Data Showing Greater Neurologic Benefit with ALXN1840 vs SoC in Wilson Disease Patients with Neurologic Symptoms at AAN 2026 https://ml.globenewswire.com/media/f8cee181-5ae9-4a02-84f5-6e35affbb72b/small/monopartherapeuticsinc-png.png https://techtimesnewyork.com/article/906832668-kimmtrak-doubles-the-likelihood-of-being-alive-at-five-years-for-first-line-hla-a-02-01-patients-with-metastatic-uveal-melanoma Tech Times of New York en PressRelease 2026-04-19T22:00:00+00:00 KIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanoma https://ml-eu.globenewswire.com/media/bcaafaab-2536-4b4b-899c-9913925b6e4b/small/immunocore-logo-2018.png https://techtimesnewyork.com/article/906832675-xenon-presents-azetukalner-phase-3-x-tole2-study-results-and-48-month-long-term-data-in-focal-onset-seizures-at-2026-aan-annual-meeting Tech Times of New York en PressRelease 2026-04-19T22:00:00+00:00 Xenon Presents Azetukalner Phase 3 X-TOLE2 Study Results and 48-Month Long-term Data in Focal Onset Seizures at 2026 AAN Annual Meeting https://ml.globenewswire.com/media/505b89d3-dfd1-46e8-bc3b-3c9c699ef7ec/small/xenon-logo-tm-full-color-250x80px-png.png https://techtimesnewyork.com/article/906816139-transactions-in-zealand-pharma-shares-and-or-related-securities-by-persons-discharging-managerial-responsibilities-and-or-their-closely-associated Tech Times of New York en PressRelease 2026-04-19T20:05:00+00:00 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons https://ml-eu.globenewswire.com/media/31b5d115-c4a3-4dfd-b20e-d222199c4862/small/zealand-logo-1-png.png https://techtimesnewyork.com/article/906816100-zealand-pharma-launches-long-term-incentive-programs-for-zealand-pharma-s-board-of-directors-corporate-management-and-employees-for-2026 Tech Times of New York en PressRelease 2026-04-19T20:00:00+00:00 Zealand Pharma launches long-term incentive programs for Zealand Pharma’s Board of Directors, Corporate Management and employees for 2026 https://ml-eu.globenewswire.com/media/31b5d115-c4a3-4dfd-b20e-d222199c4862/small/zealand-logo-1-png.png https://techtimesnewyork.com/article/906800541-revolution-medicines-to-present-updated-phase-1-clinical-data-for-zoldonrasib-in-patients-with-previously-treated-kras-g12d-non-small-cell-lung-cancer Tech Times of New York en PressRelease 2026-04-19T18:00:00+00:00 Revolution Medicines to Present Updated Phase 1 Clinical Data for Zoldonrasib in Patients with Previously Treated KRAS G12D Non-Small Cell Lung Cancer at the 2026 AACR Annual Meeting https://ml.globenewswire.com/media/771b34d9-586d-435a-a976-ab0ab847571b/small/balanced-green-primary-logo-medium-1000px-png.png https://techtimesnewyork.com/article/906785966-bronstein-gewirtz-grossman-llc-urges-power-solutions-international-inc-investors-to-act-class-action-filed-alleging-investor-harm Tech Times of New York en PressRelease 2026-04-19T16:00:00+00:00 Bronstein, Gewirtz & Grossman LLC Urges Power Solutions International, Inc. Investors to Act: Class Action Filed Alleging Investor Harm https://ml.globenewswire.com/media/1a031130-a9cc-48ff-b281-d1e47c9a91a5/small/bronstein-gewirtz-grossman-llc-logo-png.png https://techtimesnewyork.com/article/906786050-bronstein-gewirtz-grossman-llc-urges-monday-com-ltd-investors-to-act-class-action-filed-alleging-investor-harm Tech Times of New York en PressRelease 2026-04-19T16:00:00+00:00 Bronstein, Gewirtz & Grossman LLC Urges monday.com Ltd. Investors to Act: Class Action Filed Alleging Investor Harm https://ml.globenewswire.com/media/1a031130-a9cc-48ff-b281-d1e47c9a91a5/small/bronstein-gewirtz-grossman-llc-logo-png.png https://techtimesnewyork.com/article/906786052-bronstein-gewirtz-grossman-llc-urges-trip-com-group-limited-investors-to-act-class-action-filed-alleging-investor-harm Tech Times of New York en PressRelease 2026-04-19T16:00:00+00:00 Bronstein, Gewirtz & Grossman LLC Urges Trip.com Group Limited Investors to Act: Class Action Filed Alleging Investor Harm https://ml.globenewswire.com/media/1a031130-a9cc-48ff-b281-d1e47c9a91a5/small/bronstein-gewirtz-grossman-llc-logo-png.png https://techtimesnewyork.com/article/906786053-bronstein-gewirtz-grossman-llc-urges-aldeyra-therapeutics-inc-investors-to-act-class-action-filed-alleging-investor-harm Tech Times of New York en PressRelease 2026-04-19T16:00:00+00:00 Bronstein, Gewirtz & Grossman LLC Urges Aldeyra Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm https://ml.globenewswire.com/media/1a031130-a9cc-48ff-b281-d1e47c9a91a5/small/bronstein-gewirtz-grossman-llc-logo-png.png https://techtimesnewyork.com/article/906786102-bronstein-gewirtz-grossman-llc-urges-concorde-international-group-ltd-investors-to-act-class-action-filed-alleging-investor-harm Tech Times of New York en PressRelease 2026-04-19T16:00:00+00:00 Bronstein, Gewirtz & Grossman LLC Urges Concorde International Group, Ltd. Investors to Act: Class Action Filed Alleging Investor Harm https://ml.globenewswire.com/media/1a031130-a9cc-48ff-b281-d1e47c9a91a5/small/bronstein-gewirtz-grossman-llc-logo-png.png https://techtimesnewyork.com/article/906786181-bronstein-gewirtz-grossman-llc-urges-eos-energy-enterprises-inc-investors-to-act-class-action-filed-alleging-investor-harm Tech Times of New York en PressRelease 2026-04-19T16:00:00+00:00 Bronstein, Gewirtz & Grossman LLC Urges Eos Energy Enterprises, Inc. Investors to Act: Class Action Filed Alleging Investor Harm https://ml.globenewswire.com/media/1a031130-a9cc-48ff-b281-d1e47c9a91a5/small/bronstein-gewirtz-grossman-llc-logo-png.png https://techtimesnewyork.com/article/906786182-bronstein-gewirtz-grossman-llc-urges-immunitybio-inc-investors-to-act-class-action-filed-alleging-investor-harm Tech Times of New York en PressRelease 2026-04-19T16:00:00+00:00 Bronstein, Gewirtz & Grossman LLC Urges ImmunityBio, Inc. Investors to Act: Class Action Filed Alleging Investor Harm https://ml.globenewswire.com/media/1a031130-a9cc-48ff-b281-d1e47c9a91a5/small/bronstein-gewirtz-grossman-llc-logo-png.png https://techtimesnewyork.com/article/906786185-molecular-partners-presents-three-posters-at-aacr-2026-with-new-preclinical-data-for-first-switch-darpin-t-cell-engager-mp0632-and-dll3-radio-darpin Tech Times of New York en PressRelease 2026-04-19T16:00:00+00:00 Molecular Partners presents three posters at AACR 2026, with new preclinical data for first Switch-DARPin T cell engager MP0632 and DLL3 Radio-DARPin MP0712 https://ml.globenewswire.com/media/ac0d728a-e43a-4d2b-a9c5-52e74d0dd1eb/small/molecularpartners-logo-jpg.jpg https://techtimesnewyork.com/article/906781598-rosen-a-longstanding-law-firm-encourages-driven-brands-holdings-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class Tech Times of New York en PressRelease 2026-04-19T15:03:00+00:00 ROSEN, A LONGSTANDING LAW FIRM, Encourages Driven Brands Holdings Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DRVN https://ml.globenewswire.com/media/745335af-3a3a-4fb5-84c0-fdedc9adf092/small/july-30-2021-rosen-logo-jpg.jpg https://techtimesnewyork.com/article/906777333-rosen-national-trial-lawyers-encourages-concorde-international-group-ltd-investors-to-secure-counsel-before-important-deadline-in-securities-class Tech Times of New York en PressRelease 2026-04-19T14:51:00+00:00 ROSEN, NATIONAL TRIAL LAWYERS, Encourages Concorde International Group Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CIGL https://ml.globenewswire.com/media/745335af-3a3a-4fb5-84c0-fdedc9adf092/small/july-30-2021-rosen-logo-jpg.jpg https://techtimesnewyork.com/article/906749700-rosen-a-ranked-and-leading-law-firm-encourages-immunitybio-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action Tech Times of New York en PressRelease 2026-04-19T11:12:00+00:00 ROSEN, A RANKED AND LEADING LAW FIRM, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - IBRX https://ml.globenewswire.com/media/745335af-3a3a-4fb5-84c0-fdedc9adf092/small/july-30-2021-rosen-logo-jpg.jpg https://techtimesnewyork.com/article/906732361-cregis-shines-at-paris-blockchain-week-2026-accelerating-european-expansion Tech Times of New York en PressRelease 2026-04-19T09:45:18+00:00 Cregis Shines at Paris Blockchain Week 2026, Accelerating European Expansion https://ml.globenewswire.com/media/5bebd304-3269-4385-9874-50701ff2353a/medium/cover-image.jpeg https://techtimesnewyork.com/article/906711088-challenge-accepted-schneider-electric-helps-industry-turn-toughest-problems-into-competitive-advantage Tech Times of New York en PressRelease 2026-04-19T07:00:00+00:00 Challenge accepted: Schneider Electric helps industry turn toughest problems into competitive advantage https://ml.globenewswire.com/media/f9f1757e-4ed3-4fe7-939b-35cd2b1f43e1/medium/schneider-electric.jpg https://techtimesnewyork.com/article/906674833-direct-meds-glp-1-2026-claims-examined-pricing-verified-what-consumers-should-confirm-before-buying Tech Times of New York en PressRelease 2026-04-19T03:39:34+00:00 Direct Meds GLP-1 2026: Claims Examined, Pricing Verified & What Consumers Should Confirm Before Buying https://ml.globenewswire.com/media/065e49c6-04a6-4223-a1ee-caea644c6a7f/medium/direct-meds.PNG https://techtimesnewyork.com/article/906674828-strovemont-capital-claims-evaluated-is-strovemont-capital-trading-platform-legit-hidden-features-trust-facts-real-user-results Tech Times of New York en PressRelease 2026-04-19T03:10:24+00:00 Strovemont Capital Claims Evaluated: Is Strovemont Capital Trading Platform Legit? Hidden Features, Trust Facts & Real User Results https://ml.globenewswire.com/media/6c80b7b0-a3e5-46d9-a0a2-28f7c0c723bc/medium/strovemont-capital.png https://techtimesnewyork.com/article/906659883-bramridge-trust-unveiled-should-you-join-bramridge-trust-features-performance-fees-real-user-insights Tech Times of New York en PressRelease 2026-04-19T02:30:20+00:00 Bramridge Trust Unveiled: Should You Join Bramridge Trust? Features, Performance, Fees & Real User Insights! https://ml.globenewswire.com/media/298d2649-26e8-49ac-ab07-531c079947cf/medium/bramridge-trust.PNG https://techtimesnewyork.com/article/906659715-rosen-a-leading-investor-rights-law-firm-encourages-upstart-holdings-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class Tech Times of New York en PressRelease 2026-04-19T02:27:45+00:00 ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Upstart Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – UPST https://ml.globenewswire.com/media/745335af-3a3a-4fb5-84c0-fdedc9adf092/small/july-30-2021-rosen-logo-jpg.jpg https://techtimesnewyork.com/article/906659595-rosen-leading-trial-attorneys-encourages-nektar-therapeutics-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-nktr Tech Times of New York en PressRelease 2026-04-19T01:52:00+00:00 ROSEN, LEADING TRIAL ATTORNEYS, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - NKTR https://ml.globenewswire.com/media/745335af-3a3a-4fb5-84c0-fdedc9adf092/small/july-30-2021-rosen-logo-jpg.jpg https://techtimesnewyork.com/article/906659545-rosen-nationally-recognized-investor-counsel-encourages-monday-com-ltd-investors-to-secure-counsel-before-important-deadline-in-securities-class Tech Times of New York en PressRelease 2026-04-19T01:32:00+00:00 ROSEN, NATIONALLY RECOGNIZED INVESTOR COUNSEL, Encourages monday.com Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MNDY https://ml.globenewswire.com/media/745335af-3a3a-4fb5-84c0-fdedc9adf092/small/july-30-2021-rosen-logo-jpg.jpg https://techtimesnewyork.com/article/906659525-rosen-trusted-trial-attorneys-encourages-eos-energy-enterprises-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class Tech Times of New York en PressRelease 2026-04-19T01:06:00+00:00 ROSEN, TRUSTED TRIAL ATTORNEYS, Encourages Eos Energy Enterprises, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EOSE https://ml.globenewswire.com/media/745335af-3a3a-4fb5-84c0-fdedc9adf092/small/july-30-2021-rosen-logo-jpg.jpg https://techtimesnewyork.com/article/906641597-navn-important-deadline-rosen-national-investor-counsel-encourages-navan-inc-investors-with-losses-in-excess-of-100k-to-secure-counsel-before Tech Times of New York en PressRelease 2026-04-19T00:38:00+00:00 NAVN IMPORTANT DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Navan, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 24 Deadline in Securities Class Action – NAVN https://ml.globenewswire.com/media/745335af-3a3a-4fb5-84c0-fdedc9adf092/small/july-30-2021-rosen-logo-jpg.jpg https://techtimesnewyork.com/article/906641750-navn-6-day-deadline-alert-securities-class-action-alleges-navan-s-navn-ipo-materials-omitted-to-surge-in-sales-marketing-expenses-hagens-berman Tech Times of New York en PressRelease 2026-04-19T00:34:17+00:00 NAVN 6-DAY DEADLINE ALERT: Securities Class Action Alleges Navan’s (NAVN) IPO Materials Omitted to Surge in Sales & Marketing Expenses – Hagens Berman https://ml.globenewswire.com/media/2c81cd72-0ffb-43c9-9d0f-b622c3e44e43/small/11-25-2025-hbss-securities-unbold-space-1-0-png.png https://techtimesnewyork.com/article/906641706-cort-3-day-deadline-alert-hagens-berman-alerts-corcept-therapeutics-cort-investors-to-approaching-april-21st-lead-plaintiff-deadline-in-securities Tech Times of New York en PressRelease 2026-04-19T00:21:46+00:00 CORT 3-DAY DEADLINE ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Approaching April 21st Lead Plaintiff Deadline in Securities Fraud Class Action Over Relacorilant Failure https://ml.globenewswire.com/media/2c81cd72-0ffb-43c9-9d0f-b622c3e44e43/small/11-25-2025-hbss-securities-unbold-space-1-0-png.png https://techtimesnewyork.com/article/906641329-rosen-top-ranked-global-counsel-encourages-super-micro-computer-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class Tech Times of New York en PressRelease 2026-04-18T23:10:00+00:00 ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Super Micro Computer, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SMCI https://ml.globenewswire.com/media/745335af-3a3a-4fb5-84c0-fdedc9adf092/small/july-30-2021-rosen-logo-jpg.jpg https://techtimesnewyork.com/article/906622428-crypto-news-alphapepe-ai-dex-demo-over-1000-users-whilst-xrp-price-prediction-targets-5-00-following-official-sec-commodity-status Tech Times of New York en PressRelease 2026-04-18T22:45:00+00:00 Crypto News: AlphaPepe AI DEX Demo Over 1000 Users Whilst XRP Price Prediction Targets $5.00 Following Official SEC Commodity Status https://ml.globenewswire.com/media/bb8173de-d338-4af5-9802-2bcdb498429b/medium/alphapepe.jpg https://techtimesnewyork.com/article/906622143-rosen-leading-global-counsel-encourages-power-solutions-international-inc-investors-to-secure-counsel-before-important-deadline-in-securities Tech Times of New York en PressRelease 2026-04-18T21:59:00+00:00 ROSEN, LEADING GLOBAL COUNSEL, Encourages Power Solutions International, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action– PSIX https://ml.globenewswire.com/media/745335af-3a3a-4fb5-84c0-fdedc9adf092/small/july-30-2021-rosen-logo-jpg.jpg https://techtimesnewyork.com/article/906621938-rosen-national-investor-counsel-encourages-trip-com-group-limited-investors-to-secure-counsel-before-important-deadline-in-securities-class-action Tech Times of New York en PressRelease 2026-04-18T21:28:00+00:00 ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Trip.com Group Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - TCOM https://ml.globenewswire.com/media/745335af-3a3a-4fb5-84c0-fdedc9adf092/small/july-30-2021-rosen-logo-jpg.jpg https://techtimesnewyork.com/article/906621971-rosen-recognized-investor-counsel-encourages-atara-biotherapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class Tech Times of New York en PressRelease 2026-04-18T21:16:00+00:00 ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Atara Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATRA https://ml.globenewswire.com/media/745335af-3a3a-4fb5-84c0-fdedc9adf092/small/july-30-2021-rosen-logo-jpg.jpg https://techtimesnewyork.com/article/906601239-rosen-national-trial-lawyers-encourages-aldeyra-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action Tech Times of New York en PressRelease 2026-04-18T20:46:09+00:00 ROSEN, NATIONAL TRIAL LAWYERS, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ALDX https://ml.globenewswire.com/media/745335af-3a3a-4fb5-84c0-fdedc9adf092/small/july-30-2021-rosen-logo-jpg.jpg https://techtimesnewyork.com/article/906600917-nasdaq-smci-investors-who-lost-over-100-000-with-purchases-made-between-april-2024-and-march-2026-should-contact-the-shareholders-foundation-in Tech Times of New York en PressRelease 2026-04-18T20:08:13+00:00 NASDAQ: SMCI Investors who lost over $100,000 with purchases made between April 2024 and March 2026 should contact the Shareholders Foundation in connection with Lawsuit https://ml.globenewswire.com/media/f9ca95a1-d7ce-4956-a881-96550d0923bc/small/shareholders-foundation-logo-jpg.jpg https://techtimesnewyork.com/article/906034720-ereflect-inc-approved-as-vendor-for-new-york-city-public-schools Tech Times of New York en PressRelease 2026-04-18T07:00:00+00:00 eReflect Inc. Approved as Vendor for New York City Public Schools https://techtimesnewyork.com/article/906577300-pypl-deadline-monday-rosen-a-globally-respected-law-firm-encourages-paypal-holdings-inc-investors-with-losses-in-excess-of-100k-to-secure Tech Times of New York en PressRelease 2026-04-18T18:06:00+00:00 PYPL DEADLINE MONDAY: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages PayPal Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 20 Deadline in Securities Class Action - PYPL https://ml.globenewswire.com/media/745335af-3a3a-4fb5-84c0-fdedc9adf092/small/july-30-2021-rosen-logo-jpg.jpg https://techtimesnewyork.com/article/906577634-pliant-therapeutics-announces-presentation-of-updated-data-from-the-phase-1-trial-of-pln-101095-in-patients-with-ici-refractory-solid-tumors-at-the Tech Times of New York en PressRelease 2026-04-18T17:31:00+00:00 Pliant Therapeutics Announces Presentation of Updated Data from the Phase 1 Trial of PLN-101095 in Patients with ICI-Refractory Solid Tumors at the 2026 AACR Annual Meeting https://ml.globenewswire.com/media/e31d4c37-738e-4662-861d-675c8c564317/medium/figure-1.jpg https://techtimesnewyork.com/article/906577667-ring-a-ding-launches-openclaw-skill-for-ai-agent-phone-calls Tech Times of New York en PressRelease 2026-04-18T17:18:25+00:00 Ring-a-Ding Launches OpenClaw Skill for AI Agent Phone Calls https://ml.globenewswire.com/Resource/Download/d39b62af-4928-42e0-a75f-20e6a819ac8a/screenshot-2026-04-15-at-14-00-39.png https://techtimesnewyork.com/article/906577555-theriva-biologics-anuncia-la-pr-xima-presentaci-n-de-datos-adicionales-del-ensayo-cl-nico-virage-de-fase-2b-del-vcn-01-para-el-c-ncer-de-p-ncreas Tech Times of New York en PressRelease 2026-04-18T17:17:08+00:00 Theriva™ Biologics anuncia la próxima presentación de datos adicionales del ensayo clínico VIRAGE de Fase 2b del VCN-01 para el cáncer de páncreas metastásico en la Reunión Anual de la AACR de 2026 https://ml.globenewswire.com/media/ed41908b-8799-4f56-bc3c-acff4f4872eb/small/tovx-logo-jpg.jpg https://techtimesnewyork.com/article/906552421-bragar-eagel-squire-p-c-reminds-eos-energy-enterprises-inc-nasdaq-eose-investors-to-contact-the-firm-regarding-their-rights-before-may-5th Tech Times of New York en PressRelease 2026-04-18T14:05:00+00:00 Bragar Eagel & Squire, P.C. Reminds Eos Energy Enterprises, Inc. (NASDAQ:EOSE) Investors to Contact the Firm Regarding Their Rights Before May 5th https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg https://techtimesnewyork.com/article/906552347-upstart-investor-alert-bragar-eagel-squire-p-c-reminds-investors-that-a-class-action-lawsuit-has-been-filed-against-upstart-holdings-inc-and Tech Times of New York en PressRelease 2026-04-18T14:02:00+00:00 UPSTART INVESTOR ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Upstart Holdings, Inc. and Encourages Investors to Contact the Firm https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg https://techtimesnewyork.com/article/906526160-cort-deadline-alert-rosen-national-trial-counsel-encourages-corcept-therapeutics-incorporated-investors-with-losses-in-excess-of-100k-to-secure Tech Times of New York en PressRelease 2026-04-18T13:37:00+00:00 CORT DEADLINE ALERT: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Corcept Therapeutics Incorporated Investors with Losses in Excess of $100K to Secure Counsel Before Important April 21 Deadline in Securities Class Action – CORT https://ml.globenewswire.com/media/745335af-3a3a-4fb5-84c0-fdedc9adf092/small/july-30-2021-rosen-logo-jpg.jpg https://techtimesnewyork.com/article/906526085-rosen-a-highly-recognized-law-firm-encourages-soleno-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class Tech Times of New York en PressRelease 2026-04-18T13:00:00+00:00 ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Soleno Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SLNO https://ml.globenewswire.com/media/745335af-3a3a-4fb5-84c0-fdedc9adf092/small/july-30-2021-rosen-logo-jpg.jpg https://techtimesnewyork.com/article/906525665-other-world-computing-owc-launches-macdrive-12-at-nab-2026-one-solution-for-complete-mac-disk-access-on-windows-including-native-encrypted-apfs Tech Times of New York en PressRelease 2026-04-18T12:30:00+00:00 Other World Computing (OWC) Launches MacDrive 12 at NAB 2026 – One Solution for Complete Mac Disk Access on Windows - Including Native Encrypted APFS Support https://ml.globenewswire.com/media/543d94b6-063b-4931-b524-f7b75a9d230c/medium/owc-macdrive-12-application-window-screenshot.png https://techtimesnewyork.com/article/906525713-other-world-computing-launches-owc-express-4m2-ultra-at-nab-2026-thunderbolt-5-four-slot-nvme-m-2-ssd-enclosure Tech Times of New York en PressRelease 2026-04-18T12:30:00+00:00 Other World Computing Launches OWC Express 4M2 Ultra at NAB 2026 – Thunderbolt 5 Four-Slot NVMe M.2 SSD Enclosure https://ml.globenewswire.com/media/d50919d2-169d-4edd-8afc-6ca3693ad99d/medium/owc-4m2-ultra-front.png https://techtimesnewyork.com/article/906526269-tradull-develops-structured-framework-to-improve-visibility-in-commodity-trade-processes Tech Times of New York en PressRelease 2026-04-18T11:36:23+00:00 Tradull Develops Structured Framework to Improve Visibility in Commodity Trade Processes https://ml.globenewswire.com/media/e0fbd3ef-5565-4bc7-a9c9-d9d1acca96a6/medium/tradull.jpg https://techtimesnewyork.com/article/906501406-press-release-escmid-sanofi-s-nuvaxovid-covid-19-vaccine-showed-better-tolerability-than-mnexspike-in-head-to-head-study Tech Times of New York en PressRelease 2026-04-18T10:00:00+00:00 Press Release: ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study https://ml-eu.globenewswire.com/media/06da731a-67a1-4258-939f-6ef0531ee3bf/small/sanofi-new-logo-jpg.jpg https://techtimesnewyork.com/article/906501531-communiqu-de-presse-escmid-le-nuvaxovid-vaccin-contre-la-covid-19-de-sanofi-a-montr-une-meilleure-tol-rance-que-le-mnexspike-dans-une-tude Tech Times of New York en PressRelease 2026-04-18T10:00:00+00:00 Communiqué de presse : ESCMID : Le Nuvaxovid, vaccin contre la COVID-19 de Sanofi, a montré une meilleure tolérance que le mNEXSPIKE dans une étude comparative directe   https://ml-eu.globenewswire.com/media/06da731a-67a1-4258-939f-6ef0531ee3bf/small/sanofi-new-logo-jpg.jpg https://techtimesnewyork.com/article/906476329-crypto-news-alphapepe-announces-880k-raised-while-ethereum-price-prediction-targets-4-000-on-heavy-whale-accumulation Tech Times of New York en PressRelease 2026-04-18T07:00:00+00:00 Crypto News: AlphaPepe Announces $880k Raised While Ethereum Price Prediction Targets $4,000 on Heavy Whale Accumulation https://ml.globenewswire.com/media/64727b55-920f-41c6-8367-978501174859/medium/alphapepe.jpg https://techtimesnewyork.com/article/906451168-argenx-brings-neuromuscular-leadership-to-aan-2026-with-new-data-supporting-broader-vyvgart-use-across-mg-and-cidp Tech Times of New York en PressRelease 2026-04-18T05:00:00+00:00 argenx Brings Neuromuscular Leadership to AAN 2026 with New Data Supporting Broader VYVGART Use Across MG and CIDP https://ml-eu.globenewswire.com/media/be37b058-e737-46dc-b05a-c2240f4da489/small/argenx-logo-default-png.png https://techtimesnewyork.com/article/906451027-b2gold-reports-fire-related-incident-to-the-crushing-circuit-at-the-goose-mine Tech Times of New York en PressRelease 2026-04-18T03:59:18+00:00 B2Gold Reports Fire-Related Incident to the Crushing Circuit at the Goose Mine https://ml.globenewswire.com/media/d8bdd545-6088-4788-bd5a-44a0dba04191/small/3906-jpg.jpg https://techtimesnewyork.com/article/906425743-wolf-haldenstein-adler-freeman-herz-llp-announces-that-it-has-filed-a-class-action-lawsuit-against-fitness-champs-holdings-ltd-nasdaq-fchl Tech Times of New York en PressRelease 2026-04-18T03:35:00+00:00 Wolf Haldenstein Adler Freeman & Herz LLP announces that it has filed a class action lawsuit against Fitness Champs Holdings Ltd (NASDAQ: FCHL) https://ml.globenewswire.com/media/392044a3-be03-4f84-b6a6-55fda67051db/small/wolf-haldenstein-logo-main-jpg.jpg